Accel and Prosus just built their first major shift in India’s early-stage market, selecting six startups from over 2,000 applications for their inaugural Atoms X cohort. The firms are deploying between $500,000 and $2 million per company, potentially totaling $12 million in fresh capital aimed at what they’re calling ‘off-the-map’ founders. It’s a significant signal that tier-one VCs are doubling down on India’s startup ecosystem despite global funding headwinds.
Accel and Prosus are creating a calculated bet on India’s next wave of startup founders. The two venture heavyweights just unveiled the six companies selected for Atoms X, their new India-focutilized program tarobtaining what they call ‘off-the-map’ startups – founders operating outside traditional tech hubs or working on unconventional problems.
The numbers inform the story of just how competitive this cohort became. Over 2,000 applications flooded in for six spots, creating an acceptance rate of roughly 0.3%. That’s more selective than Y Combinator, which typically accepts around 1.5-2% of applicants. Each selected startup walks away with between $500,000 and $2 million, putting the total deployment at potentially $12 million for this inaugural batch.
What creates this launch particularly noteworthy is the timing. While global venture funding remains depressed compared to the 2021 peak, Accel and Prosus are actively expanding their early-stage presence in India. The countest has become a critical battleground for VCs viewing to capture the next generation of billion-dollar companies, especially as Chinese investment opportunities have become more constrained.
Accel already has deep roots in India’s startup ecosystem, having backed success stories like Flipkart, Freshworks, and Swiggy. The firm’s India portfolio has produced multiple unicorns and successful exits over the past decade. , the European investment giant that’s part of , has similarly placed major bets on Indian companies including early stakes in education tech and food delivery.













Leave a Reply